HAWK and HARRIER-Reference-Cited by-同舟云学术

HAWK and HARRIER

Published:2021-01 Issue:1 Volume:128 Page:89-99
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Dugel Pravin U.,Singh Rishi P.,Koh Adrian,Ogura Yuichiro,Weissgerber Georges,Gedif Kinfemichael,Jaffe Glenn J.,Tadayoni Ramin^ORCID,Schmidt-Erfurth Ursula,Holz Frank G.

Funder

Novartis Pharma

Heidelberg Engineering

Novartis

Sanofi

Publisher

Elsevier BV

Subject

Ophthalmology

Reference19 articles.

1. Updates on the epidemiology of age-related macular degeneration;Jonas;Asia Pac J Ophthalmol (Phila),2017

2. The estimated prevalence and incidence of late stage age related macular degeneration in the UK;Owen;Br J Ophthalmol,2012

3. Prevalence of neovascular age-related macular degeneration and geographic atrophy in Denmark;Sedeh;Dan Med J,2017

4. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration;Holz;Br J Ophthalmol,2015

5. Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration;Busbee;Ophthalmology,2013

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy;Progress in Retinal and Eye Research;2024-03

2. The Effect of a Loading Dose Regimen in the Switch to Brolucizumab for Patients with Aflibercept-Resistant nAMD;Journal of Ophthalmology;2024-01-30

3. One-year results of treat-and-extend regimen with intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration;Japanese Journal of Ophthalmology;2024-01-20

4. Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-15

5. Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration;Journal of Clinical Medicine;2024-01-10